AFT Pharmaceuticals reports FY17 loss but sees return to profit on the horizon

AFT Pharmaceuticals reports FY17 loss but sees return to profit on the horizon

By Rebecca Howard May 24 (BusinessDesk) - AFT Pharmaceuticals, which manufactures the Maxigesic painkiller, reported a full-year loss in the year to March 31 but expects to significantly narrow those deficits this year and return to profitability in the 2018/19 period. The...

Rebecca Howard 23 May 2017
Macquarie lifts F&P Healthcare price target by 7.3%

Macquarie lifts F&P Healthcare price target by 7.3%

By Rebecca Howard May 23 (BusinessDesk) - Macquarie Group lifted its 12-month target price on Fisher & Paykel Healthcare by 7.3 percent and kept its 'outperform' rating after the company's full-year revenue growth beat expectations and as a weaker New Zealand dollar weighs in...

Rebecca Howard 23 May 2017
Ebos to buy Australia's HPS for A$154 million, expanding pharmacy footprint

Ebos to buy Australia's HPS for A$154 million, expanding pharmacy footprint

By Rebecca Howard May 23 (BusinessDesk) - Ebos Group, the pharmaceutical and animal health products maker, has entered a binding agreement to acquire HPS, Australia’s largest provider of outsourced pharmacy services to hospitals, for A$154 million.  The acquisition is expec...

Rebecca Howard 22 May 2017
Final days of Trans Tasman Resources hearing underway

Final days of Trans Tasman Resources hearing underway

By Rebecca Howard May 22 (BusinessDesk) - The final days of the hearing to determine whether Trans Tasman Resources gets a green light to mine iron sands from the ocean floor in New Zealand's Exclusive Economic Zone kicked off in Wellington.  The hearing marks the second ti...

Rebecca Howard 22 May 2017